Published on:�February 28, 2018 (WASHINGTON, February 28, 2018) � Today, Senators Tim Scott (R-SC) and Cory Booker (D-NJ) introduced the Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018. This legislation will authorize a program within the Centers for Disease Control and Prevention (CDC)...

The post ASH President Applauds Legislation to Improve Sickle Cell Disease Data Collection and Care appeared first on Medical Arts Laboratory - Florida Blood Lab | Blood Draw & Test.

Published on:�April 17, 2018 (WASHINGTON, April 18, 2018) � Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study. The�study, published online today in�Blood Advances, a...

The post For Young Adults with Blood Cancer, Pediatric Centers May Improve Survival appeared first on Medical Arts Laboratory - Florida Blood Lab | Blood Draw & Test.

Publish date:�June 7, 2018 By�Christopher Palmer��Hematology News The�Food and Drug Administration has approved methoxy polyethylene glycol-epoetin beta (Mircera) for the treatment of dialysis-related anemia in pediatric�patients aged 5-17 years with chronic kidney disease whose hemoglobin had been stabilized with an erythropoiesis-stimulating agent (ESA). The approval...

The post FDA approves long-acting ESA for dialysis-related anemia in children, adolescents appeared first on Medical Arts Laboratory - Florida Blood Lab | Blood Draw & Test.